Annex

United Kingdom

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘paromomycin’ is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification
‘Paromomycin Paromomycin All food producing species 500 μg/kg Muscle
For fin fish the muscle MRL relates to ‘muscle and skin in natural proportions’.

MRLs for liver and kidney do not apply to fin fish.

Not for use in animals from which milk is produced for human consumption.
Anti-infectious agents/Antibiotics’
1 500 μg/kg Liver
1 500 μg/kg Kidney
200 μg/kg Eggs

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic Classification
‘Paromomycin	Paromomycin	All food producing species	500 μg/kg	Muscle	For fin fish the muscle MRL relates to ‘muscle and skin in natural proportions’. MRLs for liver and kidney do not apply to fin fish. Not for use in animals from which milk is produced for human consumption.	Anti-infectious agents/Antibiotics’
			1 500 μg/kg	Liver
			1 500 μg/kg	Kidney
			200 μg/kg	Eggs